Progenics Pharmaceuticals
(PGNX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1998 | 09-1998 | 06-1998 | 03-1998 | 12-1996 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | 1,160 | 570 | -160 | N/A |
| Depreciation Amortization | N/A | 360 | 220 | 110 | N/A |
| Other Working Capital | N/A | -2,370 | -1,030 | -1,000 | N/A |
| Other Operating Activity | 0 | 480 | 360 | 160 | 0 |
| Operating Cash Flow | $N/A | $-370 | $120 | $-890 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -350 | -160 | -7 | N/A |
| Other Investing Activity | 0 | -8,090 | -8,100 | -7,433 | 0 |
| Investing Cash Flow | $N/A | $-8,440 | $-8,260 | $-7,440 | $N/A |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 0 | 110 | 130 | 10 | 0 |
| Financing Cash Flow | $N/A | $110 | $130 | $10 | $N/A |
| Beginning Cash Position | N/A | 21,730 | 21,730 | 21,730 | N/A |
| End Cash Position | N/A | 13,040 | 13,720 | 13,410 | N/A |
| Net Cash Flow | $N/A | $-8,690 | $-8,010 | $-8,320 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | N/A | -370 | 120 | -890 | N/A |
| Free Cash Flow | 0 | -370 | 120 | -890 | 0 |